The Cost of Complacency: A Harm Reduction Funding Crisis

Harm Reduction International releases its annual report exploring the state of harm reduction funding in low- and middle-income countries. More

13 July 2024Advocate Advocacy Tools

Time for Change: Advancing New Drug Policies That Uphold Human Rights

To mark the Global Day of Action, 26 June, of the Support. Don’t Punish campaign, Amnesty International releases a policy paper to contribute to the advancement of drug policies that better uphold human rights. More

13 July 2024Advocate Policy Statements

2024 Global Hepatitis Report

WHO sounds alarm on viral hepatitis infections claiming 3500 lives each day. Viral hepatitis is the second leading infectious cause of death globally. More

11 April 2024Advocate Advocacy Tools

Calendar

28 July 2024

World Hepatitis Day 2024

World Hepatitis Day is commemorated each year on 28 July to enhance awareness of viral hepatitis. More

29 July 2024

Global Hepatitis Webinar – It’s Time for Action!

To mark World Hepatitis Day 2024, WHO will host a global webinar to highlight the need for the global health community to get back on track toward viral hepatitis elimination by 2030. More

18 September 2024

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 will take place in Liverpool, United Kingdom and virtually from 18 to 20 September 2024. More

19 September 2024

COLDA 2024

The 7th Conference on Liver Disease in Africa (COLDA 2024) will take place in Cairo, Egypt and virtually, from 19 to 21 September 2024. More

8 October 2024

INHSU 2024

The 12th International Conference on Health and Hepatitis Care in Substance Users (INHSU 2024) will take place in Athens, Greece from 8 to 11 October 2024. More

13 October 2024

World Health Summit 2024

The World Health Summit will take place in Berlin, Germany and virtually, from 13 to 15 October 2024. More

All events

Recent materials

Danaher Continues to Charge Exorbitant Prices for Lifesaving Medical Tests Despite Urgent Demands for Price Reductions by Several Ministries of Health

Several Ministries of Health have written to Danaher requesting that the price of the tests for XDR-TB, HIV and hepatitis — currently priced at $14.90 per test cartridge — also be lowered to no more than $7.97. More

23 June 2024News Press Releases

From Principle to Practice: Involving Communities in Research Design for Effective Hepatitis C Prevention

Unitaid’s funding to support the integration of hepatitis C testing and treatment in harm reduction services, while trialing the use of two underused products to prevent infection. More

17 June 2024News Partner News

2024 Manifesto for a Progressive EU Drug Policy

For a drug policy that makes Europe safer, healthier, and more just! A Manifesto, initiated by C-EHRN, lays down a vision for a pragmatic, innovative, and human rights-centred European drug policy. More

16 June 2024Advocate Policy Statements

HIV and Viral Hepatitis Diagnostic Tests in LMICs: Forecasts of Global and Regional Demand for 2022-2026

WHO releases a report jointly presenting diagnostic test forecasts across disease areas in recognition of the benefits of addressing HIV and viral hepatitis B and C in a coordinated manner. More

16 June 2024Advocate Advocacy Tools

Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030: WHO Report on Progress and Gaps 2024

New WHO report flags major increase in sexually transmitted infections, amidst challenges in HIV and hepatitis. More

22 May 2024Advocate Advocacy Tools